HEADER IMMUNE SYSTEM 17-MAY-24 9FE1 TITLE CRYO-EM STRUCTURE OF THE TERNARY DARPIN NY_1/HLA-A0201/NY-ESO1 TITLE 2 COMPLEX. COMPND MOL_ID: 1; COMPND 2 MOLECULE: MHC CLASS I ANTIGEN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: UNP RESIDUES 21-119; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: CANCER/TESTIS ANTIGEN 1; COMPND 12 CHAIN: C; COMPND 13 SYNONYM: AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1,CANCER/TESTIS COMPND 14 ANTIGEN 6.1,CT6.1,L ANTIGEN FAMILY MEMBER 2,LAGE-2; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: DARPIN NY_1; COMPND 18 CHAIN: D; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 22 ORGANISM_TAXID: 32630; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DARPIN TARGETING MHC MOLECULES IN COMPLEX WITH TUMOR-ASSOCIATED KEYWDS 2 PEPTIDE ANTIGENS, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR T.SCHULTE,K.WALLDEN,M.CARRONI,T.SANDALOVA,M.WALSER,S.MUELLER, AUTHOR 2 N.VENETZ,A.ACHOUR REVDAT 2 10-DEC-25 9FE1 1 JRNL REVDAT 1 28-MAY-25 9FE1 0 JRNL AUTH N.VENETZ-ARENAS,T.SCHULTE,S.MULLER,K.WALLDEN,S.FISCHER, JRNL AUTH 2 T.RESINK,N.KADRI,M.PALADINO,N.PINA,F.RADOM,D.VILLEMAGNE, JRNL AUTH 3 S.BRUCKMAIER,A.CORNELIUS,T.HOSPODARSCH,E.ALICI, JRNL AUTH 4 H.G.LJUNGGREN,B.J.CHAMBERS,X.HAN,R.SUN,M.CARRONI,V.LEVITSKY, JRNL AUTH 5 T.SANDALOVA,M.WALSER,A.ACHOUR JRNL TITL DEVELOPMENT OF DARPIN T CELL ENGAGERS FOR SPECIFIC TARGETING JRNL TITL 2 OF TUMOR-ASSOCIATED HLA/PEPTIDE COMPLEXES. JRNL REF ISCIENCE V. 28 13926 2025 JRNL REFN ESSN 2589-0042 JRNL PMID 41321628 JRNL DOI 10.1016/J.ISCI.2025.113926 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, EPU, CRYOSPARC, UCSF REMARK 3 CHIMERAX, ISOLDE, COOT, PHENIX, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 1S9W REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : THE CRYSTAL STRUCTURES OF NY_1 AND HLA REMARK 3 -A0201/NY-ESO1 (PDB 1S9W) WERE PLACED INTO THE INITIAL MAP IN REMARK 3 CHIMERAX. THE MODEL WAS ITERATIVELY REFINED BY MODEL BUILDING IN REMARK 3 COOT AND CHIMERAX-ISOLDE, AS WELL AS PHENIX REAL SPACE REMARK 3 REFINEMENT WITH INTEGRATED AMBER FORCE FIELD WITH RAMACHANDRAN, REMARK 3 SECONDARY STRUCTURE AND REFERENCE STRUCTURE RESTRAINTS REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.100 REMARK 3 NUMBER OF PARTICLES : 204743 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9FE1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAY-24. REMARK 100 THE DEPOSITION ID IS D_1292138711. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TERNARY COMPLEX FORMED BETWEEN REMARK 245 THE DARPIN NY_1 AND HLA-A0201/HB2M/NY-ESO1_157-165(9V) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : SIZE-EXCLUSION CHROMATOGRAPHY REMARK 245 (SEC) WAS USED TO PURIFY REFOLDED COMPLEXES OF HLA-A0201 WITH REMARK 245 HUMAN BETA-2-MICROGLOBULIN (HB2M) AND THE PEPTIDE NY-ESO1157- REMARK 245 165(9V). STREP-TACTIN SUPERFLOW HIGH CAPACITY COLUMNS (1 ML, IBA REMARK 245 LIFESCIENCE) RUN IN 20 MM HEPES, 300 MM NACL PH 7.5 WERE USED REMARK 245 FOR FURTHER PURIFICATION. AFTER A COLUMN WASH, THE PROTEIN WAS REMARK 245 ELUTED USING THE SAME BUFFER SUPPLEMENTED WITH 2.5 MM REMARK 245 DESTHIOBIOTIN. TEV-CLEAVED DARPIN NY_1 WAS REVERSE-PURIFIED VIA REMARK 245 IMAC AND THE MONOMER WAS ISOLATED FROM SUPERDEX 200 EQUILIBRATED REMARK 245 IN 20 MM HEPES, 150 MM NACL PH 7.5. FOR CROSS-LINKING, HLA-A0201/ REMARK 245 NY-ESO1157-165(9V) WAS MIXED IN A 1:2 MOLAR RATIO WITH NY_1, REMARK 245 CONCENTRATED TO AN ABSORBANCE AT 280 NM (ABS280) OF 2.3, AND REMARK 245 INCUBATED FOR 45 MIN IN 25 MM HEPES, 150 MM NACL, SUPPLEMENTED REMARK 245 WITH 1.4 MM BS(PEG)5 (BS5) (THERMOSCIENTIFIC). THE CROSS-LINKER REMARK 245 WAS QUENCHED BY ADDITION OF 25 MM TRIS. SAMPLES FOR GRID REMARK 245 SCREENING WERE ISOLATED FROM SUPERDEX 200 GL 10/300 SEC IN 25 MM REMARK 245 HEPES, 150 MM NACL, PH 7.4, AND CONCENTRATED TO ABS280 VALUES OF REMARK 245 2. REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 10855 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 600.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5750.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 130000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLU A 275 REMARK 465 PRO A 276 REMARK 465 GLY A 277 REMARK 465 SER A 278 REMARK 465 GLY A 279 REMARK 465 GLY A 280 REMARK 465 SER A 281 REMARK 465 ALA A 282 REMARK 465 TRP A 283 REMARK 465 SER A 284 REMARK 465 HIS A 285 REMARK 465 PRO A 286 REMARK 465 GLN A 287 REMARK 465 PHE A 288 REMARK 465 GLU A 289 REMARK 465 LYS A 290 REMARK 465 MET B 99 REMARK 465 MET D -5 REMARK 465 ARG D -4 REMARK 465 GLY D -3 REMARK 465 SER D -2 REMARK 465 HIS D -1 REMARK 465 HIS D 0 REMARK 465 HIS D 1 REMARK 465 HIS D 2 REMARK 465 HIS D 3 REMARK 465 HIS D 4 REMARK 465 GLU D 5 REMARK 465 ASN D 6 REMARK 465 LEU D 7 REMARK 465 TYR D 8 REMARK 465 PHE D 9 REMARK 465 GLN D 10 REMARK 465 GLY D 11 REMARK 465 SER D 12 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH TYR A 159 O SER C 1 1.54 REMARK 500 HG SER B 11 O HIS B 13 1.55 REMARK 500 O ASP A 129 HH11 ARG A 131 1.55 REMARK 500 O TRP A 60 HG1 THR A 64 1.56 REMARK 500 HG SER B 57 OD1 ASP B 59 1.60 REMARK 500 OG SER B 57 OD1 ASP B 59 2.04 REMARK 500 O ASP A 129 NH1 ARG A 131 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -116.49 50.81 REMARK 500 PHE A 109 107.12 -48.95 REMARK 500 THR A 178 -33.54 -135.09 REMARK 500 ARG A 219 48.18 -91.44 REMARK 500 THR A 225 44.70 -72.11 REMARK 500 GLN A 226 -82.71 -116.10 REMARK 500 ASP A 238 2.28 -68.01 REMARK 500 GLU A 254 48.49 -82.66 REMARK 500 PRO A 269 154.37 -46.65 REMARK 500 ARG B 97 -7.22 -59.80 REMARK 500 ASP D 72 99.55 -64.15 REMARK 500 HIS D 125 79.94 -100.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 48 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 9EPA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NY_1 REMARK 900 RELATED ID: EMD-50336 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE TERNARY DARPIN NY_1/HLA-A0201/NY-ESO1 REMARK 900 COMPLEX. DBREF 9FE1 A 1 276 UNP Q8WLS4 Q8WLS4_HUMAN 25 300 DBREF 9FE1 B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 9FE1 C 1 9 UNP P78358 CTG1B_HUMAN 157 165 DBREF 9FE1 D -5 169 PDB 9FE1 9FE1 -5 169 SEQADV 9FE1 MET A 0 UNP Q8WLS4 INITIATING METHIONINE SEQADV 9FE1 GLY A 277 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 SER A 278 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 GLY A 279 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 GLY A 280 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 SER A 281 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 ALA A 282 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 TRP A 283 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 SER A 284 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 HIS A 285 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 PRO A 286 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 GLN A 287 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 PHE A 288 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 GLU A 289 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 LYS A 290 UNP Q8WLS4 EXPRESSION TAG SEQADV 9FE1 MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 9FE1 VAL C 9 UNP P78358 CYS 165 CONFLICT SEQRES 1 A 291 MET GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SEQRES 2 A 291 SER ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL SEQRES 3 A 291 GLY TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER SEQRES 4 A 291 ASP ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP SEQRES 5 A 291 ILE GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR SEQRES 6 A 291 ARG LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP SEQRES 7 A 291 LEU GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA SEQRES 8 A 291 GLY SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL SEQRES 9 A 291 GLY SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR SEQRES 10 A 291 ALA TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP SEQRES 11 A 291 LEU ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR SEQRES 12 A 291 THR LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN SEQRES 13 A 291 LEU ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU SEQRES 14 A 291 ARG ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG SEQRES 15 A 291 THR ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SEQRES 16 A 291 SER ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER SEQRES 17 A 291 PHE TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP SEQRES 18 A 291 GLY GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR SEQRES 19 A 291 ARG PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA SEQRES 20 A 291 VAL VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS SEQRES 21 A 291 HIS VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU SEQRES 22 A 291 ARG TRP GLU PRO GLY SER GLY GLY SER ALA TRP SER HIS SEQRES 23 A 291 PRO GLN PHE GLU LYS SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 SER LEU LEU MET TRP ILE THR GLN VAL SEQRES 1 D 175 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLU ASN LEU SEQRES 2 D 175 TYR PHE GLN GLY SER ASP LEU GLY LYS LYS LEU LEU GLN SEQRES 3 D 175 ALA ALA ARG ALA GLY GLN LEU ASP GLU VAL ARG GLU LEU SEQRES 4 D 175 LEU LYS ALA GLY ALA ASP VAL ASN ALA LYS ASP LEU ILE SEQRES 5 D 175 GLY VAL THR PRO LEU HIS LEU ALA ALA PHE SER GLY HIS SEQRES 6 D 175 LEU GLU ILE VAL GLU VAL LEU LEU LYS ALA SER ALA ASP SEQRES 7 D 175 VAL ASN ALA LYS ASP VAL SER GLY ARG THR PRO LEU HIS SEQRES 8 D 175 VAL ALA ALA LYS HIS GLY HIS LEU GLU ILE VAL GLU VAL SEQRES 9 D 175 LEU LEU LYS ALA GLY ALA ASP VAL ASN ALA LYS ASP LEU SEQRES 10 D 175 ILE GLY PHE THR PRO LEU HIS LEU ALA ALA GLN PHE GLY SEQRES 11 D 175 HIS LEU GLU ILE VAL GLU VAL LEU LEU LYS ALA GLY ALA SEQRES 12 D 175 ASP VAL ASN ALA GLN ASP LYS SER GLY LYS THR PRO ALA SEQRES 13 D 175 ASP LEU ALA ALA ARG ALA GLY HIS GLN ASP ILE ALA GLU SEQRES 14 D 175 VAL LEU GLN LYS ALA ALA HELIX 1 AA1 TRP A 51 GLU A 55 5 5 HELIX 2 AA2 GLY A 56 TYR A 85 1 30 HELIX 3 AA3 ASP A 137 HIS A 151 1 15 HELIX 4 AA4 HIS A 151 GLY A 162 1 12 HELIX 5 AA5 GLY A 162 GLY A 175 1 14 HELIX 6 AA6 LEU D 14 GLY D 25 1 12 HELIX 7 AA7 GLN D 26 GLY D 37 1 12 HELIX 8 AA8 THR D 49 GLY D 58 1 10 HELIX 9 AA9 HIS D 59 ALA D 69 1 11 HELIX 10 AB1 THR D 82 GLY D 91 1 10 HELIX 11 AB2 HIS D 92 GLY D 103 1 12 HELIX 12 AB3 THR D 115 GLY D 124 1 10 HELIX 13 AB4 HIS D 125 ALA D 135 1 11 HELIX 14 AB5 THR D 148 GLY D 157 1 10 HELIX 15 AB6 HIS D 158 ALA D 169 1 12 SHEET 1 AA1 7 THR A 31 ASP A 37 0 SHEET 2 AA1 7 ARG A 21 VAL A 28 -1 N GLY A 26 O PHE A 33 SHEET 3 AA1 7 HIS A 3 VAL A 12 -1 N ARG A 6 O TYR A 27 SHEET 4 AA1 7 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 5 AA1 7 PHE A 109 TYR A 118 -1 O ARG A 111 N ASP A 102 SHEET 6 AA1 7 LYS A 121 LEU A 126 -1 O LEU A 126 N HIS A 114 SHEET 7 AA1 7 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AA2 4 LYS A 186 HIS A 192 0 SHEET 2 AA2 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 AA2 4 PHE A 241 PRO A 250 -1 O LYS A 243 N ALA A 205 SHEET 4 AA2 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 AA3 3 THR A 214 GLN A 218 0 SHEET 2 AA3 3 THR A 258 GLN A 262 -1 O GLN A 262 N THR A 214 SHEET 3 AA3 3 LEU A 272 ARG A 273 -1 O LEU A 272 N CYS A 259 SHEET 1 AA4 4 LYS B 6 SER B 11 0 SHEET 2 AA4 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA4 4 PHE B 62 PHE B 70 -1 O TYR B 66 N CYS B 25 SHEET 4 AA4 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 AA5 4 LYS B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O TYR B 66 N CYS B 25 SHEET 4 AA5 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA6 4 GLU B 44 ARG B 45 0 SHEET 2 AA6 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 AA6 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 AA6 4 LYS B 91 LYS B 94 -1 O VAL B 93 N CYS B 80 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.03 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 CISPEP 1 TYR A 209 PRO A 210 0 -1.08 CISPEP 2 HIS B 31 PRO B 32 0 -0.92 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 1571 2565 CONECT 2565 1571 CONECT 3200 4063 CONECT 4063 3200 CONECT 4746 5631 CONECT 5631 4746 MASTER 233 0 0 15 26 0 0 6 4295 4 6 46 END